Current position:Home >> Meeting Program >> Program
Program

Programme of VIth ICGEB Workshop on Human RNA Viruses


October 26-28, 2018, Shanghai, China


FRIDAY, 26th October 10:00-12:00 Registration & Poster setup

12:00-13:00

Lunch on your own

13:00-13:20

Opening ceremony: Welcome address -Yumei Wen and

Zheng-Hong Yuan, Fudan University, Shanghai, China

Chaired by Zhenghong Yuan and Alessandro Marcello

13:20-13:30

The International Centre for Genetic Engineering and Biotechnology

- Alessandro Marcello, ICGEB Trieste, Italy

13:30-14:00

Keynote Speech: Redefining the invertebrate RNA virosphere

-Yong-Zhen Zhang, China CDC & Fudan University, China

14:00-14:30

Keynote Speech: Emerging viruses: epidemics, drug discovery, and

vaccine development -Pei-Yong Shi, UTMB, USA

14:30-15:00

Tea/Coffee Break, Group photo & Poster Session I 


Session 1: HIV infection and AIDS

Chaired by Youhua Xie and Shibo Jiang

15:00-15:30

Virus entry inhibitors against HIV, SARS-CoV, MERS-CoV& ZIKV

- Shibo Jiang, Fudan University, China

15:30-16:00

HIV research - Vanessa M. Hirsch, NIAID, NIH, Bethesda, USA.

16:00-16:30

Human antibodies against HIV - Jinghe Huang, Fudan University, China.


Session 2: Emerging & Re-emerging Viral Diseases (I) -- Influenza virus infection

Chaired by Adolfo Garcia-Sastre and Bin Wang

16:30-17:00

Influenza virus-host interactions - Adolfo Garcia-Sastre, ICAHN School of

Medicine at Mount Sinai, USA

17:30-18:00

Protective Immune Responses during H7N9 Infection and

Universal Vaccine - Jian-Qing Xu, Fudan University, Shanghai, China.

18:00-20:0

Reception and/or Dinner

SATURDAY, 27th October


Session 3: Emerging & Re-emerging Viral Diseases (II) -- MERS-CoV infection

Chaired by Luis Enjanes and Li Chen



8:00-8:30

Human antibodies for emerging viral diseases -Dimiter S. Dimitrov,

University of Pittsburg, USA

8:30-9:00

Engineering of neutralizing monoclonal antibodies against MERS-CoV

and Zika Virus - Jing-hua Yan, Institute of Microbiology, CAS, Beijing,

China

9:00-9:30

Identification of the basis and therapeutic potential for soluble DPP4

-associated immunity to MERS-CoV infection and disease

-Chien-Te K. Tseng, UTMB, USA

9:30-10:00

Human coronaviruses virulence factors and protection - Luis Enjanes,

Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain

10:00-10:10

Tea/Coffee Break 


Session 4: Emerging & Re-emerging Viral Diseases (III) -- Ebola virus infection

Chaired by Hongzhou Lu and Qiliang Cai

10:10-10:40

Novel antibody treatment for Ebola in patients - Xiangguo Qiu, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg,

Canada

10:40-11:10

Ebola virus entry inhibitor- Lijun Rong, University of Illinois at Chicago,

USA

11:10-11:40

Clinical management of patients in the Ebola treatment center

- Hongzhou Lu, Fudan University, China

11:40-13:00

Lunch


Session 5: Emerging & Re-emerging Viral Diseases (IV) -- Flavirus infection

Chaired by Lu Lu and Shuping Tong

13:00-13:30

Story of arboviral lifecycle: acquisition mechanism from hosts to

mosquitoes - Gong Cheng, Tsinghua University, Beijing, China

13:30-14:00

Structural biology of Zika virus: what's known and unknown- Yi Shi,

Institute of Microbiology, CAS, Beijing, China

14:00-14:30

Subunit vaccines against MERS-CoV and Zika virus - Lanying Du,

New York Blood Center, USA

14:30-15:00

Flavivirus NS4B inhibitor and its unique mechanism of action

- Jinhong Chang, Baruch S. Blumberg Institute, Doylestown, USA 

15:00-15:30

Tea/Coffee Break & Poster Session II


Session 6: Novel Strategies in Prevention and Treatment of Infectious Diseases

Chaired by Benhur Lee and Jian-Hua Wang

15:30-16:00

Designer Dengue Vaccine: Neutralization without Enhancement

 - Navin Khanna

16:00-16:30

The host-cell response to Flavivirus infection - Alessandro Marcello,

ICGEB Trieste, Italy

16:30-17:00

Epidemiological characteristics of Severe fever with thrombocytopenia

syndrome (SFTS) in China from first discovery - Mi-Fang Liang,

China CDC, Beijing, China.

17:00-17:30

Engineering of paramyxovirus-based vectors for gene therapy and

vaccines -Benhur Lee, Icahn School of Medicine at Mount Sinai,

New York, USA

SUNDAY, 28th October


Session 7: HCV Infection

Chaired by Lai Weiand and Jian Wu


8:30-9:30

HCV basic virology - Jin Zhong, Shanghai Pasteur Institute, China.

9:30-10:00

From molecular virology to innate immunity of HCV infection

- Ralf Bartenschlager

10:00-10:30

HCV clinical updates with newly approved DAA  - Lai Wei,

Peking University People's Hospital, Beijing, China.

10:30-10:40

Tea/Coffee Break


Parallel Oral Presentation I

Chaired by Tianlei Ying 

10:40-10:55

To be determined                                                             To be determined

10:55-11:10

To be determined                                                             To be determined

11:10-11:25

To be determined                                                             To be determined

11:25-11:40

To be determined                                                             To be determined


Parallel Oral Presentation II

Chaired by Rong Zhang

10:40-10:55

To be determined                                                             To be determined

10:55-11:10

To be determined                                                             To be determined

11:10-11:25

To be determined                                                             To be determined

11:25-11:40

To be determined                                                             To be determined

11:55-13:30

Lunch                                                       


Parallel Oral Presentation III

Chaired by Qiao Wang

13:30-13:45

To be determined                                                             To be determined

13:45-14:00

To be determined                                                             To be determined

14:30-15:00

To be determined                                                             To be determined

15:00-15:15

To be determined                                                             To be determined


Parallel Oral Presentation IV

Chaired by Qiang Deng

13:30-13:45

To be determined                                                             To be determined
13:45-14:00
To be determined                                                             To be determined
14:30-15:00
To be determined                                                             To be determined
15:00-15:15
To be determined                                                             To be determined

15:15-15:30

Tea/Coffee Break


Session 8: HAV and HEV Infection

Chaired by Youchun Wang and Xuanyi Wang

15:30-16:00

The clinical development of HEV vaccine - Ningshao Xia,

Xiamen University, China.

16:00-16:30

The disease burden of hepatitis E and vaccine introduction in

South Asia - John Clemens, UCLA Fielding School of Public Health,

Los Angeles, USA.

16:30-17:00

Epidemiology and diagnosis of HEV infection - Youchun Wang,

National Institutes for Food and Drug Control, Beijing, China.

17:00-17:30

The status of hepatitis A in China and long term impact of HAV

immunization - Xuanyi Wang, Fudan University, China.

17:30-18:00

Award & Closing Ceremony

Chaired by Jian Wu